glp-1 gip therapy effectiveness muscle loss Preservation of lean soft tissue during weight induced by and GLP -1/GIP receptor agonists: A case series The GLP-1 revolution: What UAB
Description
Pharmacovigilance analyses identified disproportionate reporting signals for dyspnoea and asthma-like events, particularly with exenatide, using the reporting odds ratio (ROR 2.14, 95% CI 1.882.43
La pregunta ya no parece ser nicamente si estos frmacos funcionan, sino en qu pacientes, cmo utilizarlos y cmo hacerlo de forma segura
Safety issues like the black box warning for thyroid cancer risk are also addressed
How GLP-1 drugs ease joint pain and inflammation in RA, psoriatic arthritis, osteoarthritis, lupus, gout.
GLP-1 receptor agonists are counter-indicated for patients with a history of pancreatitis.
National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)
